Is CYP2C19 useful for fatigue?

CYP2C19 is a drug-metabolizing enzyme primarily relevant for processing medications like proton pump inhibitors, certain antidepressants, and clopidogrel. There is no direct link to fatigue unless an undetected drug intolerance or overdose (e.g., due to poor metabolizer status) indirectly contributes to tiredness. Evidence for a benefit in fatigue is weak: no validated studies show a causal relationship between CYP2C19 variants and general fatigue. Fatigue is multifactorial (sleep, stress, nutrition, hormones, inflammation), and a single genetic marker cannot provide reliable insight. Consumer PGx tests only screen common variants, miss rare alleles, and ignore other factors. Clinical workup (e.g., thyroid, iron, cortisol) is more appropriate. Evidence grade: mechanistic/unclear. Safety note: never use test results to change medication without consulting a physician.